Blood pressure in girls with central precocious puberty receiving GnRH analogue therapy
Journal of Pediatric Endocrinology and Metabolism · 2023
DOI: 10.1515/jpem-2023-0118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2023. Verfasst von Naama Fisch-Shvalb und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z. and Lea Shafer Institute of Endocrinology and Dia…. Hauptthemen laut MEDLINE: Puberty, Precocious. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
Case reports show hypertension in children treated with GnRH analogues for central precocious puberty (CPP). However, relevant data on blood pressure are scarce. We aimed to evaluate blood pressure (BP) among girls with idiopathic CPP and early-onset puberty before and during GnRH analogue therapy; and to examine associations of blood pressure with clinical parameters.
Methods
For this retrospective longitudinal cohort study, demographic, anthropometric, clinical, and laboratory data were collected from electronic files. The study group included 112 girls with idiopathic CPP or early-onset puberty followed in a tertiary pediatric endocrinology institute, and a control group of 37 healthy pre-pubertal girls. The main outcome measures were BP percentile, before, and during treatment with GnRH analogue.
Results
At baseline, similar proportions of the study and control groups had BP values>90th percentile: 64 (53 %) and 17 (46 %), respectively (p=0.57). The mean systolic and diastolic BP percentiles measured under treatment remained unchanged. In the study group, baseline BP>90th percentile compared to normal baseline BP was associated with lower birthweight and a higher body mass index-standard deviation score: 2,821 ± 622 vs. 3,108 ± 485 g and 1.0 ± 0.7 vs. 0.70 ± 0.8, respectively, p=0.01 for both.
Conclusions
GnRH analogue therapy for precocious or early puberty was not associated with increased blood pressure. The stability of mean blood pressure percentile during treatment is reassuring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z. and Lea Shafer Institute of Endocrinology and Diabetes, Petach Tikva, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Schneider Children's Medical Center of Israel, Institute of Nephrology, Petach Tikva, Israel.
- Faculty of Engineering, Ariel University, Ariel, Israel.
- Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Naama Fisch-Shvalb
Zitieren
APA
Fisch-Shvalb, N., Alfandary-Harani, H., Lazar, L., Davidovits, M., Shvalb, N., Demol-Eliaz, S., Yackobovitch-Gavan, M., & de Vries, L. (2023). Blood pressure in girls with central precocious puberty receiving GnRH analogue therapy. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2023-0118
Vancouver
Fisch-Shvalb N, Alfandary-Harani H, Lazar L, Davidovits M, Shvalb N, Demol-Eliaz S, et al. Blood pressure in girls with central precocious puberty receiving GnRH analogue therapy. Journal of Pediatric Endocrinology and Metabolism. 2023. doi:10.1515/jpem-2023-0118
BibTeX
@article{FischShvalb2023,
author = {Fisch-Shvalb, Naama and Alfandary-Harani, Hadas and Lazar, Liora and Davidovits, Miriam and Shvalb, Nir and Demol-Eliaz, Sharon and Yackobovitch-Gavan, Michal and de Vries, Liat},
title = {Blood pressure in girls with central precocious puberty receiving GnRH analogue therapy},
journal = {Journal of Pediatric Endocrinology and Metabolism},
year = {2023},
doi = {10.1515/jpem-2023-0118}
}
EUVIMED